Table 1 Basic clinical information, serum levels and positive rates of ANCA and ASCA of the patients and controls
Patients groups | N | Male | Female | Male:Female | Average of age (yrs) | ANCA-IgG | ASCA-IgA | ASCA-IgG |
|---|---|---|---|---|---|---|---|---|
N (%) | N (%) | N (%) | ||||||
Healthy controls | 100 | 54 | 46 | 1:0.85 | 53.19 ± 14.85 | 3.15 ± 2.24 | 1.16 ± 1.49 | 3.41 ± 5.41 |
6 (6) | 7 (7) | 8 (8) | ||||||
Disease controls | 52 | 28 | 24 | 1:0.86 | 50.88 ± 14.01 | 4.03 ± 5.96 | 0.95 ± 1.94 | 2.38 ± 3.16 |
7 (13.5) | 3 (5.77) | 1 (1.92) | ||||||
UC | 105 | 52 | 53 | 1:1.02 | 47.33 ± 15.43 | 17.5 ± 30.6a,b | 2.06 ± 9.18 | 4.05 ± 6.42 |
65 (61.9)a,b | 11 (10.5) | 13 (12.4) |